news, journals and articles from all over the world.
Researchers at Case Western Reserve University
(CWRU) and University Hospitals (UH) will study whether a new magnetic resonance imaging exam can predict how chemotherapy’s effectiveness for a woman with breast cancer based on a single round of treatment.
Susan G. Komen®, the world’s leading breast cancer organization, today announced it will host a MORE THAN PINK Walk in Arkansas this fall. The Northwest Arkansas MORE THAN PINK Walk will take place on Saturday, Oct. 7, 2023.
In a randomized trial, published in The Lancet Oncology, Mayo Clinic Comprehensive Cancer Center researchers uncover evidence supporting a shorter treatment time for breast cancer patients.
This fall, Living Beyond Breast cancer, the national patient information and support organization, is providing expert patient perspectives on patients living with breast cancer. Connect with members of the LBBC community to discuss living with breast cancer, racial equity in breast cancer health, and body image and reconstruction.
A new study led by a researcher at New York Institute of Technology provides insight that could change how scientists and clinicians understand genetic predisposition to breast cancer, a condition that affects one in eight U.S. women in her lifetime.
Americans have gotten at least 12 million more years of life to live because of preventive cancer screenings they’ve gotten the past 25 years, a new study estimates. That adds up to at least $6.5 trillion in added economic impact, because of scans and tests that look for early signs of breast, colon, cervical and lung cancer in adults at the highest risk.
Researchers from McMaster University, BC Cancer, Hamilton Heath Sciences, and the University of British Columbia have found some women with early-stage, low-risk breast cancer may not need radiotherapy after breast conserving surgery.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.
A Kaiser Permanente study provides new information that may help oncologists answer one of the most common questions they hear from breast cancer survivors: Is it safe to drink alcohol?
A study of more than 50,000 women found that continued breast cancer screening after age 70 was associated with a greater incidence of cancer that likely would not have caused symptoms in the patient’s lifetime. These findings suggest that overdiagnosis may be common among older women who are diagnosed with breast cancer after screening. The study is published in Annals of Internal Medicine.
LifeBridge Health’s new Center for Breast Health at Pomona Square offers compassionate, full-service breast care for all those in need.
The National Cancer Institute (NCI) has awarded a 5-year, $2.7 million grant to researchers at Sanford Burnham Prebys to investigate and elucidate the underlying cellular mechanisms that drive the most common form of breast cancer.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Recent developments include a novel biomarker that may predict the aggressiveness of pancreatic cancer precursors, insights into the structure and function of a breast and ovarian cancer susceptibility gene, a new approach to overcoming treatment resistance in ovarian cancer, distinguishing features of young-onset rectal cancer, a biomarker and potential target for metastatic lung cancer, machine learning models to better predict outcomes of patients with mantle cell lymphoma (MCL), and a promising therapy for patients with relapsed/refractory MCL.
The study finds utilization of annual screening mammograms suboptimal among low-income Black women with several reported perceived and actual barriers. Most had a low breast cancer risk perception. Interestingly, participants perceived mammograms as very beneficial: 80 percent believed that ‘if breast cancer is found early, it’s likely that the cancer can be successfully treated;’ 90 percent indicated that ‘having a mammogram could help find breast cancer when it is first getting started.’
Susan G. Komen commends commends the introduction of the Access to Breast Cancer Diagnosis (ABCD) Act of 2023 in the U.S. House of Representatives and the U.S. Senate. The legislation would remove a significant financial barrier to people receiving medically necessary diagnostic and supplemental breast imaging.
Researchers from the University of Liverpool have created a biomedical compound that has the potential to stop the spread of breast cancer. A recently published paper details these early findings.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Susan G. Komen®, the world’s leading breast cancer organization has launched an innovative, cloud-based, research platform specifically for breast cancer patients and survivors to share their personal health data with Komen, where it will be used to accelerate breast cancer research and help discover the cures for breast cancer.
Cancer Disparities: A new African Cancer Genome Registry at Sylvester Comprehensive Cancer Center in Miami seeks to find reasons for higher prostate and breast cancer rates in people of African ancestry. Dr. Sophia George, co-principal investigator, is available for interviews, as are two breast and prostate cancer study participants.
A study led by researchers at Sanford Burnham Prebys has found that in young women, certain genetic mutations are associated with treatment-resistant breast cancer.
Susan G. Komen® filed an amicus brief supporting the U.S. Department of Justice’s request that the Fifth Circuit Court of Appeals issue a stay in Braidwood v. Becerra.
A world-renowned biochemist joins the Sylvester Cancer team, a global health leader strives to ensure more equitable cancer care, a recent study identifies disparities in federal cancer research funding, new targeted therapies for thyroid and other cancers are making surgery a secondary option for many patients, efforts to preserve women’s sexual health while they receive endocrine therapy for breast cancer, and more are highlighted in this month’s tip sheet from Sylvester Comprehensive Cancer Center.
Breast cancer medications, called aromatase inhibitors, may lessen the effect of weight loss drugs, according to a new study being presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Women of racial and ethnic minorities experience challenges that hinder adherence to regular mammography screenings.
An observational cohort study out of Roswell Park Comprehensive Cancer Center demonstrates that race and ethnicity affect a woman’s 21-gene recurrence score, a tool used to determine risk of recurrence and distant metastasis in patients with early-stage, hormone-receptor-positive breast cancer. Based on the expression of 21 cancer-related genes detected in pre-treatment tumor specimens, recurrence score is used routinely in clinical care to identify patients who might benefit from chemotherapy as part of their treatment plan. Scores range from 0-100, with a score of 26 or higher indicating greater risk of recurrence and poorer overall survival.
Two new discoveries from the Dudley lab at UVA Cancer Center highlight the different roles of blood vessels in solid tumors – and the findings could help prevent breast cancer from spreading and enhance the effectiveness of one of the most important new cancer treatments in many years.
In addition to presenting Sylvester Comprehensive Cancer Center research findings, Sylvester experts are available at ASCO to share perspectives on a wide variety of topics and studies ranging from breast cancer to sarcoma, prostate cancer, mesothelioma, melanoma, CNS tumors and more.
Susan G. Komen thanked lawmakers in Minnesota for passing and Gov. Tim Walz for signing legislation that eliminates out-of-pocket costs for diagnostic and supplemental breast imaging.
The recommendation by the U.S. Preventive Services Task Force for women to be screened for breast cancer every other year starting at age 40 should be viewed as a starting point for a much bigger discussion, according to Dr. Brenda…
Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest research and clinical trial results on combination therapies for breast cancer, a potential new treatment for patients with recurrent glioma, and advances in PSMA PET guided radiotherapy for patients with prostate cancer, among other topics, at the American Society of Clinical Oncology’s annual meeting.
Recently, the United States Preventative Service Task Force released a draft recommendation statement on screening for breast cancer, recommending that all women get screened for breast cancer every other year starting at age 40. Rutgers Cancer Institute expert shares breast cancer data on the AAPI community.
At a glance:
Researchers trace the origin of certain breast cancers to genomic reshuffling — rearrangement of chromosomes — that activates cancer genes and ignites disease.
The finding offers a long-missing explanation for many cases of the disease that remain unexplained by the classical model of breast cancer development.
The study shows the sex hormone estrogen — thus far thought to be only a fuel for breast cancer growth — can directly cause tumor-driving genomic rearrangements.
The U.S. Preventive Services Task Force (USPSTF) has updated mammography screening guidelines for breast cancer detection to every other year beginning at age 40 instead of 50. This recommendation is based on new evidence of a rise in breast cancer…
Susan G. Komen thanked Tennessee lawmakers and Governor Bill Lee for signing legislation into law that removes out-of-pocket costs for diagnostic and supplemental breast imaging.
University Hospitals Portage Medical Center has made a number of recent investments in various areas to better serve patients in the community. Throughout the next few months, the hospital will be opening a new Breast Health Center, renovating its Cath Lab, enhancing women’s health services, and making new improvements in nuclear medicine, imaging, and across its facilities.
Linda Hovanessian Larsen, MD, a breast cancer radiologist with Keck Medicine of USC and the director of the Division of Breast Imaging at the Keck School of Medicine of USC, is available to talk about the new guidelines from the U.S.…
Repeated mammograms contain data on changes in breast density over time that could help identify women at high risk of breast cancer and even reveal which breast is likely to be affected, according to a study by researchers at Washington University School of Medicine in St. Louis.
Susan G. Komen is pleased to see that the USPSTF has taken into account more recent scientific-based evidence and believes women of average risk should begin breast cancer screening at age 40. However, Komen believes screening should be done every year to catch cancer as early as possible when outcomes are generally better and treatment costs less.
Women should begin getting regular mammograms to screen for breast cancer at age 40. That is new draft guidance from the United States Preventive Services Task Force.
New USPSTF Breast Cancer Screening Recommendations are a step in the right direction. However, the American College of Radiology and Society of Breast Imaging urge the USPSTF to go further to recommend annual mammography screening for all average-risk women ages 40 and older.
New American College of Radiology® (ACR®) breast cancer screening guidelines now call for all women — particularly Black and Ashkenazi Jewish women — to have risk assessment by age 25 to determine if screening earlier than age 40 is needed.
Acute radiation dermatitis (ARD)—characterized by red, sore, itchy or peeling skin—affects up to 95% of people undergoing radiation treatment for cancer. Severe cases can cause significant swelling and painful skin ulcers that can severely impair quality of life, yet little is known about why this condition occurs and no standardized treatments for preventing severe ARD have been widely adapted.
Susan G. Komen commended the Maryland General Assembly for passing diagnostic and supplemental imaging and Governor Wes Moore for signing it into law. The bill removes a financial barrier to a critical form of screening for some high-risk individuals and an important step in determining the need for a biopsy to rule out or confirm breast cancer.
New ACR breast cancer screening guidelines urge all women, particularly Black and Ashkenazi Jewish women, to have a risk assessment by age 25 to determine if screening before age 40 is needed. The ACR urges average-risk women to start yearly screening at 40, but earlier screening for high-risk women.
Ochsner Health has medical experts on standby to discuss a recent study on new risk for breast cancer, college students struggling with mental health, and World Hunger Day. Breast density as a new risk for cancer – A recently published…
Susan G. Komen applauded Oklahoma lawmakers and Governor Kevin Stitt for implementing legislation to prohibit the use of step therapy requirements for metastatic cancer patients.
Susan G. Komen®, the world’s leading breast cancer organization, has appointed nine world-renowned medical and research experts to serve as advisors to the organization. These breast cancer experts will be part of a distinguished group, known as Komen Scholars, who help guide Komen’s research and scientific programs, with a focus on advancing discoveries to improve breast cancer outcomes for everyone.
Institute, including three new centers, will lead research to foster novel discoveries and explore new treatments for a range of diseases from leukemia to Alzheimer’s disease.
Susan G. Komen® commends passage of diagnostic and supplemental imaging legislation in Montana. The bill was signed into law by Governor Greg Gianforte.
NCCN has published a new addition to its library of patient resources, expanding the information available for breast cancer. The new NCCN Guidelines for Patients: Inflammatory Breast Cancer joins patient and caregiver resources for Breast Cancer Screening and Diagnosis, Ductal Carcinoma In Situ, Invasive Breast Cancer, and Metastatic Breast Cancer.
English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
Urdu